TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.

H Josh Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.